Radiant Innovation

Radiant Innovation Days Payable Outstanding

The Days Payable Outstanding (DPO) of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is 30.04. In the previous year, Days Payable Outstanding (DPO) was 32.29 — a change of -6.95% (lower).

Days Payable Outstanding

30.04

YoY

-6.95%

Last updated:

Days Payable Outstanding (DPO) of Radiant Innovation is 2025 30.04 . Days Payable Outstanding (DPO) of Radiant Innovation was 2024 32.29 . It decreases by -6.95% lower compared to the previous year.

The Radiant Innovation Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2018
41.93 TWD
Jan 1, 2019
47.21 TWD
Jan 1, 2020
61.91 TWD
Jan 1, 2021
31.13 TWD
Jan 1, 2022
28.96 TWD
Jan 1, 2023
21.29 TWD
Jan 1, 2024
32.29 TWD
Jan 1, 2025
30.04 TWD
The Radiant Innovation Days Payable Outstanding history
YEARDays Payable OutstandingYoY
30.04-6.95%
32.29+51.67%
21.29-26.48%
28.96-7.00%
31.13-49.71%
61.91+31.14%
47.21+12.59%
41.93-21.61%
53.49+13.05%
47.32+6.03%
44.63-33.97%
67.59—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Days Payable Outstanding (DPO) of Radiant Innovation is 30.04 in 2025.

Days Payable Outstanding (DPO) of Radiant Innovation changed from 32.29 to 30.04, representing a -6.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Radiant Innovation with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Radiant Innovation

All Key Metrics — Radiant Innovation